BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36158687)

  • 1. Clinical significance and prognostic value of small nucleolar RNA SNORA38 in breast cancer.
    Song J; Zheng A; Li S; Zhang W; Zhang M; Li X; Jin F; Ji Z
    Front Oncol; 2022; 12():930024. PubMed ID: 36158687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
    Zheng A; Zhang L; Song X; Wang Y; Wei M; Jin F
    BMC Cancer; 2019 May; 19(1):451. PubMed ID: 31088422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H/ACA box small nucleolar RNA 7B acts as an oncogene and a potential prognostic biomarker in breast cancer.
    Sun Y; Chen E; Li Y; Ye D; Cai Y; Wang Q; Li Q; Zhang X
    Cancer Cell Int; 2019; 19():125. PubMed ID: 31168298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEAD-box helicase 27 enhances stem cell-like properties with poor prognosis in breast cancer.
    Li S; Ma J; Zheng A; Song X; Chen S; Jin F
    J Transl Med; 2021 Aug; 19(1):334. PubMed ID: 34362383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
    Li X; Li Y; Yu X; Jin F
    J Transl Med; 2020 Aug; 18(1):331. PubMed ID: 32867770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression scoring of a small-nucleolar-RNA signature identified by machine learning serves as a prognostic predictor for head and neck cancer.
    Xing L; Zhang X; Zhang X; Tong D
    J Cell Physiol; 2020 Nov; 235(11):8071-8084. PubMed ID: 31943178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
    Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Small Nucleolar RNA SNORD60 as a Potential Biomarker and Its Clinical Significance in Lung Adenocarcinoma.
    Zhou H; Yao Y; Li Y; Guo N; Zhang H; Wang Z; Chen Y; Dai G
    Biomed Res Int; 2022; 2022():5501171. PubMed ID: 35711521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Aurora Kinase A as a Biomarker for Prognosis in Obesity Patients with Early Breast Cancer.
    Jiang J; Guo Z; Xu J; Sun T; Zheng X
    Onco Targets Ther; 2020; 13():4971-4985. PubMed ID: 32581556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
    Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
    Front Genet; 2022; 13():760514. PubMed ID: 35273635
    [No Abstract]   [Full Text] [Related]  

  • 13. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
    Chen S; Duan H; Xie Y; Li X; Zhao Y
    Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
    Meng X; Wang L; He M; Yang Z; Jiao Y; Hu Y; Wang K
    PLoS One; 2022; 17(6):e0269998. PubMed ID: 35771747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Eight Small Nucleolar RNAs as Survival Biomarkers and Their Clinical Significance in Gastric Cancer.
    Wang X; Xu M; Yan Y; Kuang Y; Li P; Zheng W; Liu H; Jia B
    Front Oncol; 2019; 9():788. PubMed ID: 31552164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of the diagnostic and prognostic value associated with the
    Yan L; He J; Liao X; Liang T; Zhu J; Wei W; He Y; Zhou X; Peng T
    Gland Surg; 2022 Feb; 11(2):389-411. PubMed ID: 35284318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker.
    Hu H; Wang ZW; Hu S; Xiang Y; Deng Y; Wan FJ; Zhang TC; Yang ZY; Liao XH
    Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37387422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of tumor immune infiltration-related snoRNAs for predicting tumor immune microenvironment status and prognosis in lung adenocarcinoma.
    Wan R; Bai L; Cai C; Ya W; Jiang J; Hu C; Chen Q; Zhao B; Li Y
    Comput Struct Biotechnol J; 2021; 19():6386-6399. PubMed ID: 34938414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
    Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
    J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.